Integrated Transcriptomic and Metabolomic Analysis of Rat PASMCs Reveals the Underlying Mechanism for Pulmonary Arterial Hypertension
American Journal of Hypertension · 2025
DOI: 10.1093/ajh/hpaf015 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hypertension, 2025. Verfasst von Jie Hou und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Henan University, Kaifeng, China. Hauptthemen laut MEDLINE: Pulmonary Artery, Myocytes, Smooth Muscle, Transcriptome, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Pulmonary arterial hypertension (PAH) is a kind of pulmonary vascular lesion characterized by vasoconstriction and reshaping of small pulmonary arteries, ultimately resulting in increased pulmonary artery pressure and pulmonary vascular resistance, and eventually leading to right ventricular failure and death. This study was aimed to construct a platelet-derived growth factor BB (PDGF-BB)-induced rat pulmonary artery smooth muscle cells (PASMCs) model and conduct a combined transcriptomic and metabolomic analysis to identify proliferation-related targets, thereby enhancing the understanding of the pathogenesis underlying PAH. METHODS Rat PASMCs were isolated and cultured in the presence or absence of PDGF-BB for 24 hours. Cells were collected for transcriptomics and metabolomics investigations. RESULTS A total of 1,288 differentially expressed genes (DEGs; 572 upregulated and 716 downregulated) were identified in PDGF-BB-treated rat PASMCs compared with control cells. Subsequently, Gene ontology (GO) enrichment analysis revealed that 791 enriched GO terms were significantly enriched in PDGF-BB treated cells. Similarly, 294 differential metabolic pathways were enriched in PDGF-BB-treated cells according to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Gene Set Enrichment Analysis was performed on the DEGs. It turned out that 7,219 gene sets were more enriched in PDGF-BB treated cells. In addition, a total of 28 secondary differential metabolites were identified in PDGF-BB-treated rat PASMCs compared with control cells (P-value < 0.05 and VIP > 1). CONCLUSIONS We speculate that Mylk, Pla2g4a, Gucy1b1, Adcy8, Adcy4, Gucy1a2, Col3a1, and Plcb4 are potential targets for the treatment of PAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Henan University, Kaifeng, China.
- Pharmacy Department of Huaihe Hospital, Henan University, Kaifeng, China.
- State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
ORCID-Profile: Jun-Zhuo Shi
Zitieren
APA
Hou, J., Liu, K., Zhang, M. J., Xu, X. H., Meng, F. F., Wang, C. C., Yang, O., Zhao, L. L., Wang, M. W., Zhou, Y. F., Pang, X. B., He, Y. Y., Kou, J. J., Xie, X. M., Zhang, H. D., & Shi, J. Z. (2025). Integrated Transcriptomic and Metabolomic Analysis of Rat PASMCs Reveals the Underlying Mechanism for Pulmonary Arterial Hypertension. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf015
Vancouver
Hou J, Liu K, Zhang MJ, Xu XH, Meng FF, Wang CC, et al. Integrated Transcriptomic and Metabolomic Analysis of Rat PASMCs Reveals the Underlying Mechanism for Pulmonary Arterial Hypertension. American Journal of Hypertension. 2025. doi:10.1093/ajh/hpaf015
BibTeX
@article{Hou2025,
author = {Hou, Jie and Liu, Ke and Zhang, Meng-Jie and Xu, Xiao-He and Meng, Fang-Fang and Wang, Chen-Chen and Yang, Ou and Zhao, Lu-Ling and Wang, Meng-Wei and Zhou, Yun-Feng and Pang, Xiao-Bin and He, Yang-Yang and Kou, Jie-Jian and Xie, Xin-Mei and Zhang, Hong-Da and Shi, Jun-Zhuo},
title = {Integrated Transcriptomic and Metabolomic Analysis of Rat PASMCs Reveals the Underlying Mechanism for Pulmonary Arterial Hypertension},
journal = {American Journal of Hypertension},
year = {2025},
doi = {10.1093/ajh/hpaf015}
}
EUVIMED